Free Trial

GoodRx (GDRX) Short Interest Ratio & Short Volume

$7.16
+0.03 (+0.42%)
(As of 05/21/2024 ET)

GoodRx Short Interest Data

Current Short Interest
9,690,000 shares
Previous Short Interest
9,720,000 shares
Change Vs. Previous Month
-0.31%
Dollar Volume Sold Short
$75.49 million
Short Interest Ratio
5.7 Days to Cover
Last Record Date
February 29, 2024
Outstanding Shares
375,205,000 shares
Float Size
76,640,000 shares
Short Percent of Float
12.64%
Today's Trading Volume
1,158,946 shares
Average Trading Volume
1,558,541 shares
Today's Volume Vs. Average
74%
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook
Short Selling GoodRx ?

Sign up to receive the latest short interest report for GoodRx and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

GDRX Short Interest Over Time

GDRX Days to Cover Over Time

GDRX Percentage of Float Shorted Over Time

GoodRx Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
2/29/20249,690,000 shares $75.49 million -0.3%12.6%5.7 $7.79
2/15/20249,720,000 shares $65.42 million -0.2%12.8%6.3 $6.73
1/31/20249,740,000 shares $58.44 million +1.5%13.1%5.5 $6.00
1/15/20249,600,000 shares $63.74 million +18.1%12.9%5.3 $6.64
12/31/20238,130,000 shares $54.47 million +2.9%10.9%5.2 $6.70
12/15/20237,900,000 shares $50.01 million -11.2%10.6%5.6 $6.33
11/30/20238,900,000 shares $53.31 million +10.2%12.2%6.6 $5.99
11/15/20238,080,000 shares $42.66 million +11.8%13.5%6.4 $5.28
10/31/20237,230,000 shares $35.64 million -13.3%10.8%5.6 $4.93
10/15/20238,340,000 shares $44.29 million +5.6%11.2%4.8 $5.31
9/30/20237,900,000 shares $44.48 million +1.7%10.6%3.9 $5.63
9/15/20237,770,000 shares $46.62 million +12.0%10.5%3.9 $6.00
8/31/20236,940,000 shares $45.32 million +53.9%9.4%3.5 $6.53
8/15/20234,510,000 shares $33.28 million -13.1%6.1%2.3 $7.38
7/31/20235,190,000 shares $47.96 million +2.6%7.4%2.9 $9.24
7/15/20235,060,000 shares $37.75 million +1.2%7.7%3.9 $7.46
6/30/20235,000,000 shares $27.60 million -4.0%7.6%4.6 $5.52
6/15/20235,210,000 shares $30.11 million +7.2%8.0%4.6 $5.78
5/31/20234,860,000 shares $26.39 million -1.6%7.4%3.4 $5.43
5/15/20234,940,000 shares $25.69 million No Change7.5%3.1 $5.20
10/31/202211,900,000 shares $63.90 million -2.5%N/A3.7 $5.37
10/15/202212,200,000 shares $57.95 million -3.2%N/A3.6 $4.75
9/30/202212,600,000 shares $58.84 million +6.4%18.8%3.8 $4.67
9/15/202211,840,000 shares $77.08 million -12.2%17.6%3.6 $6.51
8/31/202213,490,000 shares $82.29 million -10.3%20.2%4.2 $6.10
8/15/202215,040,000 shares $108.44 million -19.3%22.4%4.8 $7.21
7/31/202218,640,000 shares $116.13 million -0.2%28.9%6.9 $6.23
7/15/202218,670,000 shares $121.92 million +1.4%28.9%8.5 $6.53
6/30/202218,420,000 shares $109.05 million +2.3%28.5%8.4 $5.92
6/15/202218,010,000 shares $112.74 million +26.4%27.9%8.2 $6.26
5/31/202214,250,000 shares $113.57 million +22.0%21.7%6 $7.97
5/15/202211,680,000 shares $103.95 million +11.6%17.8%3.6 $8.90
4/30/202210,470,000 shares $141.87 million -8.0%15.4%3.8 $13.55
4/15/202211,380,000 shares $211.67 million +12.7%16.7%4.3 $18.60
3/31/202210,100,000 shares $195.23 million -8.6%N/A3.7 $19.33
3/15/202211,050,000 shares $166.08 million -30.9%16.5%3.9 $15.03
2/28/202215,980,000 shares $437.85 million +10.6%25.5%6.1 $27.40
2/15/202214,450,000 shares $421.65 million -6.1%23.0%9 $29.18
1/31/202215,390,000 shares $369.51 million -3.1%23.2%9.4 $24.01
1/15/202215,880,000 shares $426.38 million +3.9%N/A0 $26.85
The Presidential candidate you should REALLY be worried about (Ad)

The Presidential candidate you should REALLY be worried about Most Americans are overlooking the seemingly impossible candidate that should worry you. It's not Biden… Trump… Newsom… or even Michelle. It's someone even worse. New evidence of a secret plan indicates he could soon return, and finish what he started.

Get the full story right here.
12/31/202115,290,000 shares $499.68 million +2.1%22.4%10.3 $32.68
12/15/202114,970,000 shares $562.42 million +3.7%21.9%10.3 $37.57
11/30/202114,430,000 shares $576.05 million -1.8%21.3%10.1 $39.92
11/15/202114,690,000 shares $588.19 million -10.4%21.9%9.9 $40.04
10/29/202116,400,000 shares $731.44 million -1.2%26.0%10.2 $44.60
10/15/202116,590,000 shares $703.75 million +7.2%26.3%10.1 $42.42
9/30/202115,470,000 shares $634.58 million -3.0%24.5%9.1 $41.02
9/15/202115,950,000 shares $706.43 million -2.2%25.5%9.1 $44.29
8/31/202116,310,000 shares $620.11 million -14.6%26.5%9.5 $38.02
8/13/202119,100,000 shares $708.23 million +18.5%30.9%10.7 $37.08
7/30/202116,120,000 shares $516.97 million -1.8%28.1%8.2 $32.07
7/15/202116,420,000 shares $491.61 million +0.1%28.7%8.4 $29.94
6/30/202116,410,000 shares $590.92 million -2.7%28.7%8.6 $36.01
6/15/202116,870,000 shares $631.78 million -5.2%29.5%8.1 $37.45
5/28/202117,790,000 shares $660.19 million +8.1%31.1%7.4 $37.11
5/14/202116,460,000 shares $465.32 million +12.4%28.3%6.9 $28.27
4/30/202114,640,000 shares $592.63 million +12.5%25.6%7.1 $40.48
4/15/202113,010,000 shares $490.09 million +1.1%24.9%5.9 $37.67
3/31/202112,870,000 shares $488.29 million +10.3%27.1%5.8 $37.94
3/15/202111,670,000 shares $455.71 million +20.7%24.8%5.5 $39.05
2/26/20219,670,000 shares $440.47 million +6.4%29.7%4.9 $45.55
2/12/20219,090,000 shares $491.59 million -10.0%27.7%3.8 $54.08
1/29/202110,100,000 shares $487.22 million -21.2%28.4%3.4 $48.24
1/15/202112,810,000 shares $566.97 million No Change36.0%4.4 $44.26

GDRX Short Interest - Frequently Asked Questions

What is GoodRx's current short interest?

Short interest is the volume of GoodRx shares that have been sold short but have not yet been covered or closed out. As of February 29th, traders have sold 9,690,000 shares of GDRX short. 12.64% of GoodRx's shares are currently sold short. Learn More on GoodRx's current short interest.

What is a good short interest ratio for GoodRx?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. GDRX shares currently have a short interest ratio of 6.0. Learn More on GoodRx's short interest ratio.

Which institutional investors are shorting GoodRx?

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of GoodRx: Walleye Trading LLC, and Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

What is a good short interest percentage for GoodRx?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 12.64% of GoodRx's floating shares are currently sold short.

Is GoodRx's short interest increasing or decreasing?

GoodRx saw a decline in short interest during the month of February. As of February 29th, there was short interest totaling 9,690,000 shares, a decline of 0.3% from the previous total of 9,720,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is GoodRx's float size?

GoodRx currently has issued a total of 375,205,000 shares. Some of GoodRx's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. GoodRx currently has a public float of 76,640,000 shares.

How does GoodRx's short interest compare to its competitors?

12.64% of GoodRx's shares are currently sold short. Here is how the short interest of companies compare to GoodRx: Merus (5.76%), Progyny, Inc. (8.56%), Certara, Inc. (5.23%), Bausch Health Companies Inc. (5.73%), Inari Medical, Inc. (7.59%), MoonLake Immunotherapeutics (14.00%), Celldex Therapeutics, Inc. (10.61%), Fortrea Holdings Inc. (7.41%), ICU Medical, Inc. (5.57%), Maravai LifeSciences Holdings, Inc. (6.66%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($4.39 billion), General Motors ($3.88 billion), Super Micro Computer, Inc. ($3.51 billion), Charter Communications, Inc. ($3.22 billion), Occidental Petroleum Co. ($3.13 billion), Tractor Supply ($2.76 billion), Coinbase Global, Inc. ($2.63 billion), Suncor Energy Inc. ($2.48 billion), Moderna, Inc. ($2.04 billion), and Royal Caribbean Cruises Ltd. ($1.87 billion). View all of the most shorted stocks.

What does it mean to sell short GoodRx stock?

Short selling GDRX is an investing strategy that aims to generate trading profit from GoodRx as its price is falling. GDRX shares are trading up $0.03 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against GoodRx?

A short squeeze for GoodRx occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of GDRX, which in turn drives the price of the stock up even further.

How often is GoodRx's short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including GDRX, twice per month. The most recent reporting period available is February, 29 2024.



More Short Interest Resources from MarketBeat

This page (NASDAQ:GDRX) was last updated on 5/21/2024 by MarketBeat.com Staff

From Our Partners